Cargando…
Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer
SIMPLE SUMMARY: Immunotherapy has emerged as an attractive alternative to conventional therapies for the clinical management of prostate cancer (PCa); it not only specifically targets malignant cells while protecting healthy tissue, but it also appears to augment the therapeutic effect of existing t...
Autores principales: | Adamaki, Maria, Zoumpourlis, Vassilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825410/ https://www.ncbi.nlm.nih.gov/pubmed/33419051 http://dx.doi.org/10.3390/cancers13020173 |
Ejemplares similares
-
The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis
por: Tsintarakis, Antonis, et al.
Publicado: (2023) -
DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
por: Liouta, Galateia, et al.
Publicado: (2023) -
CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
por: Baliou, Stella, et al.
Publicado: (2018) -
Personalized immunotherapy in cancer precision medicine
por: Kiyotani, Kazuma, et al.
Publicado: (2021) -
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
por: Papalouka, Chara, et al.
Publicado: (2023)